Other
Change in AR
Vertex Pharmaceuticals Change in AR decreased by 140.0% to -$39.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 123.5%, from $169.60M to -$39.80M. Over 2 years (FY 2022 to FY 2025), Change in AR shows relatively stable performance with a -3.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
A significant increase may signal aggressive revenue recognition or collection issues, while a decrease suggests improved cash conversion cycles.
Detailed definition
The net change in the balance of accounts receivable during the reporting period, representing the difference between cr...
Peer comparison
Should track closely with revenue growth; significant deviations from revenue trends warrant investigation.
Metric ID:
anet_change_in_accounts_receivableHistorical Data
17 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $185.30M | $43.50M | $165.20M | $84.10M | $119.50M | $0.00 | $21.03M | $21.03M | $21.03M | $21.03M | $251.60M | $51.80M | $169.60M | $18.40M | $59.90M | $99.40M | -$39.80M |
| QoQ Change | — | -76.5% | +279.8% | -49.1% | +42.1% | -100.0% | — | +0.0% | +0.0% | +0.0% | >999% | -79.4% | +227.4% | -89.2% | +225.5% | +65.9% | -140.0% |
| YoY Change | — | — | — | — | -35.5% | -100.0% | -87.3% | -75.0% | -82.4% | — | >999% | +146.4% | -32.6% | — | +15.6% | — | -123.5% |
Range-$39.80M – $251.60M
CAGR-31.9%
Avg YoY Growth+72.2%
Median YoY Growth-55.3%
Change in AR at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in ar?
- Vertex Pharmaceuticals (VRTX) reported change in ar of -$39.80M in Q1 2026.
- How has Vertex Pharmaceuticals's change in ar changed year-over-year?
- Vertex Pharmaceuticals's change in ar decreased by 123.5% year-over-year, from $169.60M to -$39.80M.
- What is the long-term trend for Vertex Pharmaceuticals's change in ar?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's change in ar has grown at a -3.0% compound annual growth rate (CAGR), from $368.80M to $347.30M.
- What does change in ar mean?
- The net increase or decrease in money owed to the company by customers.